GNR Analytical Instruments Group, thanks to its 30 years of experience and innovation, is a worldwide market manufacturer of advanced analytical instruments, developing procedures of analysis for various applications, supplying the corresponding laboratory equipment and providing consulting and customer support worldwide, through its post sales network.
GNR was established in 1984 in Milan (Italy) founded by Mario Gungui and Antonio Nigro.
They took over OPTICA srl, one of the first and most well-known european companies in the field of analytical instrumentation. In the first years, an extensive development program, according to the most advanced technologies leads brings to the development of a range of innovative instruments in the OES domain replacing obsolete equipment.
The continuos effort kept for the overall years of activity allowed GNR to reach a prominent place among the most important worldwide manufactures of optical emission spectrometers (OES), supplying GNR unit all over the world.
Product Portfolio Differentiation: X-Ray Domain
In 2004 a balanced policy, aimed to consolidate and diversify the production, led to the acquisition of ItalStructures srl. ItalStructures was founded in 1966 and was specialised in the production of X-Ray Analytical Instruments. It was present on the main international markets, in research centres as well as in the metallurgic, chemical, pharmaceutical, electronic, environmental, and food industry.
Later, two other important shareholdings operations have been executed, with ORI Instruments srl (Electronic design), and with Laser Point srl (Laser instrumentation). Moreover an agreement with XGlab srl, spinoff of Politecnico di Milano, specialized in the study and development of high tech detectors, has been defined.
With 30 years of technological experience, GNR is a worldwide market producer of advanced X-ray (XRD, XRF) and Optical Emission Spectrometer (OES) systems for complete solutions in structural and elemental analysis with thousands of machines installed and operative all over the world.
Every year an important percentage of its revenue is invested in R&D with the aim to improve the performance of its product portfolio.